Author:
Han Haote,Chou Chih-Chien,Li Ruyi,Liu Jiangyun,Zhang Lin,Zhu Wei,Hu Jin,Yang Bingxian,Tian Jingkui
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Lin, J., Wang, C. & Kelly, W. K. Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions. Semin. Oncol. 40, 393–401 (2013).
2. Schneider, B. P. et al. Triple-negative breast cancer: risk factors to potential targets. Clin. Cancer. Res. 14, 8010–8018 (2008).
3. Gelmon, K. et al. Targeting triple-negative breast cancer: optimising therapeutic outcomes. Ann. Surg. Oncol. 23, 2223–34 (2012).
4. Brady-West, D. C. & Mcgrowder, D. A. Triple negative breast cancer: therapeutic and prognostic implications. Asia. Pac. J. Cancer P. 12, 2139–43 (2011).
5. Hennessy, B. T. et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 69, 4116–4124 (2009).
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献